BD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Vaccination Agility and Preparedness
- BD
FRANKLIN LAKES, N.J., Oct. 7, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has strengthened the U.S. government’s access to safety injection devices through increased manufacturing capacity and domestic supply. Read more…
Related Reading
Resource / Government & Legislative Affairs
Scott Whitaker Op-Ed: Medicare must keep pace with FDA-authorized breakthrough medical technologies
February 27, 2026
Medicare breakthrough medical technologies face delays between FDA authorization and coverage decisions, slowing patient access to innovation.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
Navigating the ACCESS Model: A Direct Dialogue with CMMI Leadership
March 6, 2026
2:00 PM – 3:00 PM
Join AdvaMed for an exclusive member-only webinar featuring a direct dialogue with CMS Innovation Center leadership on the newly released ACCESS Model. Attendees will gain critical insights into model performance metrics, payment pathways, and opportunities for the MedTech industry.
Resource / Artificial Intelligence (AI) / Coverage & Payment / Digital Health / Regulatory Affairs
AdvaMed® Comment Letter to ASTP/ONC: Accelerating AI Adoption in Clinical Care
February 24, 2026
AdvaMed’s® Comment Letter to ASTP/ONC, outlines concrete policy reforms across FDA oversight, CMS payment pathways, and HIPAA data-sharing rules to accelerate patient access to AI-enabled medical technologies. As AI-enabled medical devices transform patient care, outdated regulatory, coverage, and privacy frameworks are slowing the pace of adoption.
News / Artificial Intelligence (AI) / Regulatory Affairs
i-GENTIC AI Launches Context-Aware MedTech Agents to Strengthen FDA 510(k) Submission Consistency
February 23, 2026
PALO ALTO, Calif., Feb. 11, 2026 i-GENTIC AI today announced a new suite of context-aware, multilingual MedTech agents designed to help medical device manufacturers improve the quality and consistency of FDA 510(k) submissions. Preparing a 510(k) often takes months, yet many submissions require additional information requests or are rejected due to inconsistencies across documents, evidence, and claims, creating delays and added costs for manufacturers.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
The Supreme Court Struck Down IEEPA Tariffs – What Medtech Needs To Know
February 26, 2026
1:00 PM – 2:00 PM
Now On Demand
Resource / Government & Legislative Affairs / Policy Briefings
AdvaMed® 2026 State Policy Briefing Series
February 23, 2026
Explore the 2026 State Policy Briefing Series for insights on medtech policy, legislative activity, and regulatory updates impacting the medtech industry.
Blog / Regulatory Affairs
Why Practical FDA Submissions Training Makes the Difference
February 17, 2026
Explore AdvaMed’s Medical Device Submissions Workshop Series from practical submission strategies to live expert insights you can apply immediately.
Blog / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access
Heart Month: Why Sleep Apnea Belongs at the Center of Cardiovascular Care
February 13, 2026
February is American Heart Month—a time to spotlight cardiovascular disease and highlight innovations that can improve patient outcomes. For the medtech community, it’s an opportunity to address persistent gaps in care through technology, data, collaboration, and policy advancement. Despite progress in treating heart conditions, sleep disorders—especially sleep apnea—remain a significant and underrecognized contributor to poor cardiovascular outcomes.1 Tackling this issue requires clinical awareness and supportive policies for timely diagnosis, coverage, and care beyond traditional settings.